Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment image
2 min read
  • Industries

FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment

Pharm'Up
LENZ Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted approval for...
Read More Read more about FDA Approves VIZZ: A Breakthrough Eye Drop for Presbyopia Treatment
AKTU – B. Pharm. 2nd Semester (First Year) image
1 min read
  • Previous Papers

AKTU – B. Pharm. 2nd Semester (First Year)

Pharm'Up
HUMAN ANATOMY AND PHYSIOLOGY-II THEORY (BP201T) HUMAN-ANATOMY-AND-PHYSIOLOGY-II (BP201T) MAY-2025 BP201T Human Anatomy and Physiology II – Theory...
Read More Read more about AKTU – B. Pharm. 2nd Semester (First Year)
Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data image
3 min read
  • Pharma News

Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data

Pharm'Up
Merck has revealed that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review...
Read More Read more about Merck’s Winrevair™ Gains FDA Priority Review Following Stellar ZENITH Trial Data
Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis image
2 min read
  • Industries

Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis

Pharm'Up
Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...
Read More Read more about Novartis Reveals Phase III GCAptAIN Trial Outcomes: Cosentyx Misses Primary Target for Giant Cell Arteritis
Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market image
1 min read
  • Industries

Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market

Pharm'Up
Global pharmaceutical leader Lupin Limited has unveiled the launch of Ipratropium Bromide Nasal Solution (Nasal Spray) in...
Read More Read more about Lupin Introduces Ipratropium Bromide Nasal Spray in the U.S. Market
Biocon Biologics Gains UK Approval for Denosumab Biosimilars image
1 min read
  • Industries

Biocon Biologics Gains UK Approval for Denosumab Biosimilars

Pharm'Up
Biocon Biologics Ltd. (BBL), a leading global biosimilars company and subsidiary of Biocon Ltd., has received marketing...
Read More Read more about Biocon Biologics Gains UK Approval for Denosumab Biosimilars
AKTU – B. Pharm. 1st Semester (First Year) image
1 min read
  • Previous Papers

AKTU – B. Pharm. 1st Semester (First Year)

Pharm'Up
HUMAN ANATOMY AND PHYSIOLOGY-I THEORY (BP101T) HUMAN-ANATOMY-AND-PHYSIOLOGY-I (BP101T) MAY-2025 BP101T Human Anatomy and Physiology I– Theory BP102T...
Read More Read more about AKTU – B. Pharm. 1st Semester (First Year)
Global Heart Disease Toll Linked to Widespread Plastic Chemical Exposure image
2 min read
  • Pharma News

Global Heart Disease Toll Linked to Widespread Plastic Chemical Exposure

Pharm'Up
A comprehensive study by NYU Langone Health revealed a significant link between daily exposure to di-2-ethylhexyl phthalate...
Read More Read more about Global Heart Disease Toll Linked to Widespread Plastic Chemical Exposure
Novartis Achieves Historic Approval for Pioneering Malaria Treatment for Newborns and Young Infants image
2 min read
  • Industries

Novartis Achieves Historic Approval for Pioneering Malaria Treatment for Newborns and Young Infants

Pharm'Up
Novartis achieved a major milestone in global child health with the Swissmedic approval of Coartem® Baby (artemether-lumefantrine),...
Read More Read more about Novartis Achieves Historic Approval for Pioneering Malaria Treatment for Newborns and Young Infants
Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar image
2 min read
  • Industries

Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar

Pharm'Up
Lupin Limited, a global pharmaceutical leader, and Zentiva Group, a prominent pan-European pharmaceutical company, announced a landmark...
Read More Read more about Lupin and Zentiva Forge Strategic Partnership for Global Commercialization of Certolizumab Pegol Biosimilar

Posts pagination

Previous 1 … 169 170 171 172 173 174 175 … 180 Next

Recent Posts

  • Understanding Small Intestine Cancer: Risks, Symptoms, and Treatment
  • Infant Reflux (GER) and GERD: Spitting Up and Growth
  • Understanding Reflux (GER) and GERD in Children
  • Gastroenteritis: Understanding the “Stomach Bug” and Food Poisoning
  • Stomach Health: Understanding Function and Common Disorders

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Understanding Small Intestine Cancer: Risks, Symptoms, and Treatment

Pharm'Up
Pharmup 20
2 min read
  • Disease

Infant Reflux (GER) and GERD: Spitting Up and Growth

Pharm'Up
Pharmup 19
2 min read
  • Disease

Understanding Reflux (GER) and GERD in Children

Pharm'Up
Pharmup 18
2 min read
  • Disease

Gastroenteritis: Understanding the “Stomach Bug” and Food Poisoning

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.